Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Chromothripsis during telomere crisis is independent of NHEJ, and consistent with a replicative origin.

Cleal K, Jones RE, Grimstead JW, Hendrickson EA, Baird DM.

Genome Res. 2019 May;29(5):737-749. doi: 10.1101/gr.240705.118. Epub 2019 Mar 14.

2.

DNA damage signalling from the placenta to foetal blood as a potential mechanism for childhood leukaemia initiation.

Mansell E, Zareian N, Malouf C, Kapeni C, Brown N, Badie C, Baird D, Lane J, Ottersbach K, Blair A, Case CP.

Sci Rep. 2019 Mar 13;9(1):4370. doi: 10.1038/s41598-019-39552-0.

3.

Telomere fusions associate with coding sequence and copy number alterations in CLL.

Escudero L, Cleal K, Ashelford K, Fegan C, Pepper C, Liddiard K, Baird DM.

Leukemia. 2019 Aug;33(8):2093-2097. doi: 10.1038/s41375-019-0423-y. Epub 2019 Feb 22. No abstract available.

4.

Telomere length predicts for outcome to FCR chemotherapy in CLL.

Norris K, Hillmen P, Rawstron A, Hills R, Baird DM, Fegan CD, Pepper C.

Leukemia. 2019 Aug;33(8):1953-1963. doi: 10.1038/s41375-019-0389-9. Epub 2019 Jan 30.

PMID:
30700843
5.

PARP inhibition prevents escape from a telomere-driven crisis and inhibits cell immortalisation.

Ngo G, Hyatt S, Grimstead J, Jones R, Hendrickson E, Pepper C, Baird D.

Oncotarget. 2018 Dec 25;9(101):37549-37563. doi: 10.18632/oncotarget.26499. eCollection 2018 Dec 25.

6.

DNA Ligase 1 is an essential mediator of sister chromatid telomere fusions in G2 cell cycle phase.

Liddiard K, Ruis B, Kan Y, Cleal K, Ashelford KE, Hendrickson EA, Baird DM.

Nucleic Acids Res. 2019 Mar 18;47(5):2402-2424. doi: 10.1093/nar/gky1279.

7.

Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes.

Garcia-Martin I, Penketh RJA, Janssen AB, Jones RE, Grimstead J, Baird DM, John RM.

PLoS One. 2018 Dec 11;13(12):e0208533. doi: 10.1371/journal.pone.0208533. eCollection 2018.

8.

PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ.

Harvey A, Mielke N, Grimstead JW, Jones RE, Nguyen T, Mueller M, Baird DM, Hendrickson EA.

Oncotarget. 2018 Oct 5;9(78):34821-34837. doi: 10.18632/oncotarget.26201. eCollection 2018 Oct 5.

9.

Salivary Gland Stem Cells Age Prematurely in Primary Sjögren's Syndrome.

Pringle S, Wang X, Verstappen GMPJ, Terpstra JH, Zhang CK, He A, Patel V, Jones RE, Baird DM, Spijkervet FKL, Vissink A, Bootsma H, Coppes RP, Kroese FGM.

Arthritis Rheumatol. 2019 Jan;71(1):133-142. doi: 10.1002/art.40659.

10.

Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary.

Pilsworth JA, Cochrane DR, Xia Z, Aubert G, Färkkilä AEM, Horlings HM, Yanagida S, Yang W, Lim JLP, Wang YK, Bashashati A, Keul J, Wong A, Norris K, Brucker SY, Taran FA, Krämer B, Staebler A, van Meurs H, Oliva E, Shah SP, Kommoss S, Kommoss F, Gilks CB, Baird DM, Huntsman DG.

Mod Pathol. 2019 Apr;32(4):593. doi: 10.1038/s41379-018-0085-8.

PMID:
29968850
11.

Telomeres and Chromosomal Translocations : There's a Ligase at the End of the Translocation.

Baird DM, Hendrickson EA.

Adv Exp Med Biol. 2018;1044:89-112. doi: 10.1007/978-981-13-0593-1_7. Review.

PMID:
29956293
12.

Human TSCM cell dynamics in vivo are compatible with long-lived immunological memory and stemness.

Costa Del Amo P, Lahoz-Beneytez J, Boelen L, Ahmed R, Miners KL, Zhang Y, Roger L, Jones RE, Marraco SAF, Speiser DE, Baird DM, Price DA, Ladell K, Macallan D, Asquith B.

PLoS Biol. 2018 Jun 22;16(6):e2005523. doi: 10.1371/journal.pbio.2005523. eCollection 2018 Jun.

13.

The C-Terminal Extension Unique to the Long Isoform of the Shelterin Component TIN2 Enhances Its Interaction with TRF2 in a Phosphorylation- and Dyskeratosis Congenita Cluster-Dependent Fashion.

Nelson ND, Dodson LM, Escudero L, Sukumar AT, Williams CL, Mihalek I, Baldan A, Baird DM, Bertuch AA.

Mol Cell Biol. 2018 May 29;38(12). pii: e00025-18. doi: 10.1128/MCB.00025-18. Print 2018 Jun 15.

14.

TERT promoter mutation in adult granulosa cell tumor of the ovary.

Pilsworth JA, Cochrane DR, Xia Z, Aubert G, Färkkilä AEM, Horlings HM, Yanagida S, Yang W, Lim JLP, Wang YK, Bashashati A, Keul J, Wong A, Norris K, Brucker SY, Taran FA, Krämer B, Staebler A, van Meurs H, Oliva E, Shah SP, Kommoss S, Kommoss F, Gilks CB, Baird DM, Huntsman DG.

Mod Pathol. 2018 Jul;31(7):1107-1115. doi: 10.1038/s41379-018-0007-9. Epub 2018 Feb 15. Erratum in: Mod Pathol. 2018 Jul 3;:.

15.

CCR8 Expression Defines Tissue-Resident Memory T Cells in Human Skin.

McCully ML, Ladell K, Andrews R, Jones RE, Miners KL, Roger L, Baird DM, Cameron MJ, Jessop ZM, Whitaker IS, Davies EL, Price DA, Moser B.

J Immunol. 2018 Mar 1;200(5):1639-1650. doi: 10.4049/jimmunol.1701377. Epub 2018 Feb 2.

16.

Telomere Length Dynamics and the Evolution of Cancer Genome Architecture.

Cleal K, Norris K, Baird D.

Int J Mol Sci. 2018 Feb 6;19(2). pii: E482. doi: 10.3390/ijms19020482. Review.

17.

Telomeres and genomic evolution.

Baird DM.

Philos Trans R Soc Lond B Biol Sci. 2018 Mar 5;373(1741). pii: 20160437. doi: 10.1098/rstb.2016.0437. Review.

18.

Telomere length is an independent prognostic marker in MDS but not in de novo AML.

Williams J, Heppel NH, Britt-Compton B, Grimstead JW, Jones RE, Tauro S, Bowen DT, Knapper S, Groves M, Hills RK, Pepper C, Baird DM, Fegan C.

Br J Haematol. 2017 Jul;178(2):240-249. doi: 10.1111/bjh.14666. Epub 2017 May 9.

PMID:
28486748
19.

Telomere erosion in NF1 tumorigenesis.

Jones RE, Grimstead JW, Sedani A, Baird D, Upadhyaya M.

Oncotarget. 2017 Jun 20;8(25):40132-40139. doi: 10.18632/oncotarget.16981.

20.

Structural and functional analysis of the human POT1-TPP1 telomeric complex.

Rice C, Shastrula PK, Kossenkov AV, Hills R, Baird DM, Showe LC, Doukov T, Janicki S, Skordalakes E.

Nat Commun. 2017 Apr 10;8:14928. doi: 10.1038/ncomms14928.

Supplemental Content

Loading ...
Support Center